Michigan Orthopaedic & Spine Surgeons   Report issue

Academic/Hospital Phase 4
Founded: Rochester Hills MI United States (2017)

Organization Overview

First Clinical Trial
2020
NCT04245371
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

John Papakonstantinou, MD | Michigan Orthopaedic & Spine Surgeons

Active Ingredients

Drugs in Phase 4 Trials (1)

lidocaine (xylocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carpal Tunnel Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1